Stay updated on THB001 Efficacy in Chronic Cold Urticaria Clinical Trial

Sign up to get notified when there's something new on the THB001 Efficacy in Chronic Cold Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the THB001 Efficacy in Chronic Cold Urticaria Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:30:53.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the data related to a phase 1b clinical trial for adult patients with chronic cold urticaria, specifically focusing on the safety, pharmacokinetics, and pharmacodynamic effects of THB001.
    Difference
    0.2%
    Check dated 2024-06-06T14:38:17.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying that researchers are looking for men and women aged 18-75 diagnosed with chronic, cold inducible urticaria for at least 3 months and refractory to antihistamine treatment. Previously, no information was provided under Participation Criteria.
    Difference
    20%
    Check dated 2024-05-22T21:32:45.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:47:46.000Z thumbnail image

Stay in the know with updates to THB001 Efficacy in Chronic Cold Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the THB001 Efficacy in Chronic Cold Urticaria Clinical Trial page.